You are either bu11#$%$ here or a novice investor. The last patient visit marks the end of the trial and the lock down of the database. The event just happened few days back. The analysis will take several weeks. Any data released to the press after trial will be facts, rather than forward looking statements, and it has to analyzed, reviewed and certified, good or bad.
Sentiment: Strong Buy